Clinical Trials in Dallas

Showing 17201-17220 of 17,468 trials

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma

NCT00383851

This is a multicenter, randomized, phase II study to evaluate the safety and efficacy of oral ATN-224 plus temozolomide in patients with advanced melanoma. Patients will be randomized (1:1) between temozolomide and ATN-224 and temozolomide followed by ATN-224. Patients assigned to the sequential treatment group will receive temozolomide until progression of disease is documented and then receive ATN-224 as a single agent until documentation of progression of disease using the last tumor assessment on temozolomide therapy as the baseline assessment.

Melanoma

Attenuon60 participantsStarted Sep 2006

Tucson, Arizona, United States • Encinitas, California, United States • Orange, California, United States +14 more locations

TERMINATEDPhase 2/3< 1 mile

Study Evaluating the Efficacy of DVS-233 in Fibromyalgia

NCT00301431

The purpose of this study is to determine if DVS-233 is safe and effective in the treatment of pain and other symptoms of fibromyalgia syndrome.

Fibromyalgia

Wyeth is now a wholly owned subsidiary of Pfizer1,050 participantsStarted Aug 2006

Huntsville, Alabama, United States • Mobile, Alabama, United States • Phoenix, Arizona, United States +56 more locations

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma

Study Evaluating the Efficacy of DVS-233 in Fibromyalgia

Find Trials by Condition in Dallas

Amphotericin B Suspension in Refractory Chronic Sinusitis

A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.

Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department

Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression

Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis

DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder

A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular Degeneration

Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis

A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder

Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)

[S,S]-Reboxetine Long Term Safety Study In Post-Shingles Pain.

Prospective Study to Identify Patients at Risk of Dangerous Ventricular Arrhythmias

Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse

Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of Death